{"id":3872,"date":"2014-02-12T15:12:44","date_gmt":"2014-02-12T15:12:44","guid":{"rendered":"\/?p=3872"},"modified":"2014-02-12T15:12:53","modified_gmt":"2014-02-12T15:12:53","slug":"cannabis-science-inc-otcmktscbis-still-crashing","status":"publish","type":"post","link":"\/articles\/cannabis-science-inc-otcmktscbis-still-crashing\/","title":{"rendered":"Cannabis Science, Inc. (OTCMKTS:CBIS) Still Crashing"},"content":{"rendered":"\n

Cannabis Science, Inc. (OTCMKTS:CBIS<\/a>) finished another session in the red yesterday, with a fall of 6.21%.<\/p>\n

The company has lost more than 44% of its market value over the course of the last four sessions. This is certainly a tragic development for CBIS<\/a> stock owners, if not an entirely unexpected one.<\/p>\n

The end of last week and the beginning of this one was hard for other companies as well. Companies such as Medical Marijuana Inc(OTCMKTS:MJNA<\/a>), GreenGro Technologies, Inc.(OTCMKTS:GRNH<\/a>) and Plandai Biotechnology Inc(OTCMKTS:PLPL<\/a>) all registered significant drops in market value, but nowhere is the fall so dramatic as with CBIS<\/a> share prices. <\/p>\n

Evidently not pumping out multiple meaningless press releases to incite buyers to invest aggressively can cause a company to lose ground really fast in the market’s current unstable state.<\/p>\n

The company’s present state of decline can easily be attributed to their media inertia and a failure to exploit the hype the way many others are doing right now. However, even if they did try to ride the hype to the top of the charts, CBIS<\/a> would still be fighting an uphill battle, because of its financial problems.<\/p>\n

Sadly CBIS<\/a> is anything but financially sound, as we’ve mentioned on many previous occasions. The figures in its latest financial report speak for themselves. As does the fact that the company’s president, a mr. Robert Melamede, has sold more than 1.7 million shares of his common stock this month alone.<\/p>\n

<\/p>\n

Keeping in mind the market’s present volatility, pennystock enthusiasts should probably heed FINRA’s warning and do some extra due diligence before committing to high risk stocks.<\/p>\n","protected":false},"excerpt":{"rendered":"

Cannabis Science, Inc. (OTCMKTS:CBIS) finished another session in the red yesterday, with a fall of 6.21%. The company has lost more than 44% of its market value over the course of the last four...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[229,262,8,470],"class_list":["post-3872","post","type-post","status-publish","format-standard","hentry","category-news","tag-cbis","tag-grnh","tag-mjna","tag-plpl"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=3872"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/3872\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=3872"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=3872"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=3872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}